Welcome to our dedicated page for Cannabix Technol news (Ticker: BLOZF), a resource for investors and traders seeking the latest updates and insights on Cannabix Technol stock.
Cannabix Technologies Inc. (BLOZF) specializes in pioneering breath analysis systems for substance detection, serving law enforcement and safety-critical industries worldwide. This dedicated news hub provides investors and professionals with timely updates on technological advancements, regulatory achievements, and strategic partnerships driving the future of autonomous screening solutions.
Discover official announcements covering product certifications, patent approvals, and deployment in judicial monitoring systems. Our curated feed includes verified press releases about device integrations in workplace safety programs, industrial testing environments, and international market expansions.
Key updates feature developments in delta-9 THC detection accuracy, collaborations with forensic laboratories, and progress toward global regulatory compliance. Stay informed about innovations in contactless sampling technology and advancements in data-logging systems designed for evidentiary applications.
Bookmark this page for streamlined access to essential updates about Cannabix's role in modernizing substance testing protocols. Check regularly for new developments in breathalyzer technology that combine forensic precision with operational efficiency across multiple industries.
Cannabix Technologies and Omega Laboratories have reported positive early results from testing their marijuana breathalyzer technology. Omega has initiated pre-validation work to establish detection limits for delta-9 THC, the primary psychoactive component of cannabis. Omega scientists have successfully quantified delta-9 THC in low picogram ranges using Cannabix's Breath Collection Unit (BCU). The partnership aims to advance the development and commercialization of this technology, with Omega providing extensive expertise in forensic drug testing. The collaboration includes hardware refinement, marketing, and preparation for multiple validation studies.
Cannabix Technologies and Omega Laboratories have entered a strategic partnership to commercialize Cannabix's marijuana breathalyzer technology. The agreement, effective from May 15, 2024, involves research and development, validation, and commercialization phases. Omega will be the exclusive laboratory in North America for analyzing Cannabix's delta9 THC breathalyzer samples for five years. Omega will receive 1,000,000 common shares and up to 11,000,000 special warrants of Cannabix upon achieving specific milestones. The partnership aims to enhance drug detection technology and expand its market reach in North America.
Cannabix Technologies Inc. has launched its new compact Breath Logix Workplace Series alcohol breath detection device designed for indoor facilities and offices. The company is in discussions with Run Rite Electronics Pty in South Africa for potential sales distribution. The device offers pre-access alcohol testing, random testing, start-of-shift testing, pre-employment testing, return-to-work testing, and post-incident testing. It automatically checks user sobriety, records identity, delivers Blood Alcohol Content (BAC) levels, sends real-time alerts, and logs user BAC for incident reporting. The device aims to promote organizational safety and reduce accidents linked to alcohol consumption.
Cannabix Technologies Inc. is collaborating with Breathalyser Sales & Service Pty in Australia to distribute its new Breath Logix Alcohol screening device. This device offers features like pre-calibrated cartridge technology, automatic BAC level detection, and real-time alerts for users in various sectors. Cannabix aims to provide an innovative solution for alcohol screening in workplaces and other settings.
FAQ
What is the current stock price of Cannabix Technol (BLOZF)?
What is the market cap of Cannabix Technol (BLOZF)?
